Nama Insights

Mettler-Toledo International (MTD)

Healthcare · Diagnostics Research · NYSE

S&P 500
Mettler-Toledo International (MTD) is a Healthcare company in the Diagnostics Research industry. It has a market capitalization of $34.51B, a trailing price-to-earnings ratio of 37.2 and a free-cash-flow yield of 2.4%. Over the most recent reported fiscal year, revenue grew 4.0% and free cash flow per share grew 1.2%. Nama's AI scorecard rates it Buy, 6.6 out of 10. On 12-month momentum it ranks in the middle band of its market.
AI scorecard
Buy · 6.6/10
Positive, at the low end of Buy. As of Nov 7, 2026.
Momentum
Middle · +6.5% over 12 months ex. last
Middle fifth of its market on the past year's move.
Shariah screen
Shariah Compliant
Passes our debt, cash and income screen; not a scholar's ruling.
Off its high
-4.7%
How far the last close sits under the highest price of the past five years.
Market cap$34.51B
Trailing P/E37.2
Price / book2690.9
Price / sales8.3
FCF yield2.4%
Dividend yield—
Gross margin60.3%
Operating margin28.4%
Net margin21.9%
Revenue growth (YoY)+4.0%
Revenue growth (3-yr annual)+0.9%
EPS growth (YoY)+4.0%
FCF/share growth (YoY)+1.2%
Beta1.2
ExchangeNYSE
SectorHealthcare
IndustryDiagnostics Research

MTD earnings

Next report: Feb 4, 2027 (Q4 2026, EPS estimate $14.88). Beat the EPS estimate in 4 of 4 recent quarters.

QuarterReportedEPSEstimateSurpriseRevenue
Q3 2026 Nov 5, 2026 $12.57 $12.09 +4.0% —
Q2 2026 Jul 30, 2026 $11.46 $10.80 +6.1% $1.03B
Q1 2026 May 7, 2026 $8.91 $8.71 +2.3% $947.13M
Q4 2025 Feb 5, 2026 $13.36 $12.81 +4.3% $1.13B

MTD analyst price target

Median target $1,565.00 from 12 analysts, ranging $1,200.00 – $1,700.00.

Diagnostics Research peers

TickerCompanyMarket capP/E
TMO Thermo Fisher Scientific $257.42B 28.1
DHR Danaher $161.86B 27.6
IDXX IDEXX Laboratories $53.26B 45.6
A Agilent Technologies $49.28B 28.8
WAT Waters $44.93B 31.8
IQV IQVIA $44.80B 21.2
NTRA Natera $44.78B —
ILMN Illumina $32.23B 40.6
Explore live MTD data on Nama Insights →

Recent Congressional trades

Mettler-Toledo International trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →

Member Chamber Trade Amount Disclosed
Julia Letlow House Sell $1,001 - $15,000 Jan 13, 2026
Julia Letlow House Buy $1,001 - $15,000 Jan 13, 2026
Julia Letlow House Buy $1,001 - $15,000 Jan 13, 2026
Rob Bresnahan House Buy $1,001 - $15,000 May 31, 2025
Julie Johnson House Sell $1,001 - $15,000 May 14, 2025
Rob Bresnahan House Sell $1,001 - $15,000 Apr 28, 2025
Susan M Collins Senate Buy $1,001 - $15,000 —
Susan M Collins Senate Buy $15,001 - $50,000 —

MTD FAQ

Is MTD a buy?
Nama's AI scorecard currently rates Mettler-Toledo International Buy (6.6 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.
What is MTD's P/E ratio?
Mettler-Toledo International trades at a trailing price-to-earnings ratio of 37.2.
When does MTD report earnings?
Mettler-Toledo International's next scheduled report is on Feb 4, 2027. Analysts expect EPS of $14.88.
What is the MTD price target?
The median analyst price target from 12 analysts is $1,565.00, with a range of $1,200.00 – $1,700.00.
Is MTD Shariah compliant?
Nama's AAOIFI-style screen reads Mettler-Toledo International as Shariah Compliant. Passes our debt, cash and income screen; not a scholar's ruling.